Exploring the Therapeutic Landscape: The Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients With Cirrhosis

被引:0
|
作者
Gudushauri, Nino [1 ]
Lemonjava, Irakli [1 ]
Azmaiparashvili, Zurab [1 ]
Mohan, Nandakumar [2 ]
Tskhakaia, Irakli [1 ]
Byfield, Karecia [3 ]
Anebo, Tinsae [3 ]
机构
[1] Jefferson Einstein Hosp, Philadelphia, PA USA
[2] Einstein Healthcare Network, Philadelphia, PA USA
[3] Albert Einstein Med Ctr, Philadelphia, PA USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词
D O I
10.14309/01.ajg.0001036756.32599.c9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1847
引用
收藏
页码:S1330 / S1330
页数:1
相关论文
共 50 条
  • [1] The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart Failure
    Nakagaito, Masaki
    Imamura, Teruhiko
    Ushijima, Ryuichi
    Nakamura, Makiko
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [2] SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks
    Loyola-Velez, Alejandro J.
    John, Binu V.
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (02) : 456 - 458
  • [3] SGLT2 inhibitors in clinical practice
    Ryden, Lars
    Norhammar, Anna
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 434 - 435
  • [4] Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities
    Pandey, Aparamita
    Alcaraz Jr, Martin
    Saggese, Pasquale
    Soto, Adriana
    Gomez, Estefany
    Jaldu, Shreya
    Yanagawa, Jane
    Scafoglio, Claudio
    CANCERS, 2025, 17 (03)
  • [5] Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action
    Piperis, Christos
    Marathonitis, Anastasios
    Anastasiou, Artemis
    Theofilis, Panagiotis
    Mourouzis, Konstantinos
    Giannakodimos, Alexios
    Tryfou, Elsi
    Oikonomou, Evangelos
    Siasos, Gerasimos
    Tousoulis, Dimitris
    BIOMEDICINES, 2024, 12 (10)
  • [6] SGLT2 Inhibitors and Heart Failure Outcomes
    Chim, Christine
    Newaz, Shahreear
    US PHARMACIST, 2020, 45 (02) : 18 - 22
  • [7] SGLT2 inhibitors and the changing landscape for treatment of diabetes
    Liu, Shuangbo
    Lam, Anna
    Wazir, Arslan
    Cheema, Asim N.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 861 - 867
  • [8] Effects of SGLT2 inhibitors on cardiovascular outcomes
    Foote, Celine
    Perkovic, Vlado
    Neal, Bruce
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 117 - 123
  • [9] SGLT2 Inhibitors in Liver Patients
    Hsiang, John Chen
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) : 2168 - +
  • [10] IMPACT OF SGLT2 INHIBITORS ON MORTALITY IN PULMONARY ARTERIAL HYPERTENSION: EXPLORING THE ASSOCIATION
    Lemonjava, Irakli
    Gudushauri, Nino
    Tskhakaia, Irakli
    Manzano, Jose Manuel Martinez
    Azmaiparashvili, Zurab
    CHEST, 2024, 166 (04) : 5793A - 5793A